BAY81-8781

acetylsalicylic acid, intravenous formulation · Bayer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BAY81-8781, covering 2015-06-25 to 2015-06-25. Get the full timeline:

Most recent: Clinical Trial Update: BAY81-8781, I.V. Aspirin in the Indication of Acute Coronary Syndrome (ACS) [Phase 3]